Large logo of Inflarx


Flag of GermanyGermany

InflaRx (Nasdaq: IFRX) is a biopharmaceutical business in the late stages of clinical development with a focus on leveraging its unique technology to identify and create pioneering, potent, and selective C5a inhibitors. C5a, a component of the complement system, plays a significant role in the advancement of various autoimmune and inflammatory conditions. Founded in 2007, InflaRx operates from locations in Jena and Munich, Germany, and Ann Arbor, MI, USA.